首页> 外文OA文献 >Trastuzumab Resistance: What Are We Offering to Breast Cancer Patients?

【2h】

Trastuzumab Resistance: What Are We Offering to Breast Cancer Patients?

机译：曲妥珠单抗抵抗：我们提供给乳腺癌患者的内容是什么？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Sonel Patel; Nandini Hayes; Maria Teresa Esposito;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population [J] . Fan Yang, Xiang Huang, Chunxiao Sun, BMC Cancer . 2020,第1期

机译：Lapatinib与Capecitabine相结合，继续使用Trastuzumab在胸腺癌患者的胸瘤患者：中国人口的回顾性研究
2. Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment [J] . Agnieszka Adamczyk, Anna Kruczak, Agnieszka Harazin-Lechowska, OncoTargets and therapy . 2018,第2期

机译：HER2基因状态与曲妥珠单抗耐药相关的潜在潜在生物学特征的关系及其对接受曲妥珠单抗辅助治疗的乳腺癌患者生存的影响
3. Trastuzumab plus capecitabine vs. lapatinib plus capecitabine in patients with trastuzumab resistance and taxane-pretreated metastatic breast cancer [J] . BianL., WangT., ZhangS., Tumour biology : . 2013,第5期

机译：曲妥珠单抗耐药和紫杉烷预处理的转移性乳腺癌患者中曲妥珠单抗加卡培他滨与拉帕替尼加卡培他滨对比
4. Association of Multi-Drug Resistance-1 (MDR1) Gene Polymorphism with Leukocytopenia in Breast Cancer Patients treated with Chemotherapy [C] . Siti Syarifah, Tri Widyawati, Kamal B. Siregar, Public Health International Conference . 2017

机译：化疗治疗乳腺癌患者白细胞凋亡的多药抗性-1（MDR1）基因多态性的关联
5. HER2Delta16: a tumor-specific oncogene that drives tumorigenesis and trastuzumab resistance in HER2+ breast cancer. [D] . Huynh, Felicia C. 2015

机译：HER2Delta16：一种肿瘤特异性癌基因，可驱动HER2 +乳腺癌的肿瘤发生和曲妥珠单抗。
6. Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population [O] . Fan Yang, Xiang Huang, Chunxiao Sun, 2020

机译：拉帕替尼联合卡培他滨与曲妥珠单抗耐药的乳腺癌患者继续使用曲妥珠单抗的回顾性研究
7. Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer [O] . Milos Dokmanovic, Dianne S. Hirsch, Yi Shen, 2009

机译：RAC1有助于乳腺癌细胞的曲妥珠单抗抗性：RAC1作为治疗抗胸瘤乳腺癌的潜在治疗靶标
8. Overcoming Resistance to Trastuzumab in HER2-Amplified Breast Cancers [R] . Moody, S. 2011

机译：克服HER2扩增乳腺癌对曲妥珠单抗的耐药性

Trastuzumab Resistance: What Are We Offering to Breast Cancer Patients?

著录项

引文网络

相似文献

相关主题

期刊订阅